Login / Signup
Xu Li
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 4
Top Topics
Escherichia Coli
Cell Therapy
Top Venues
Chemical communications (Cambridge, England)
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Garrick W K Spencer
,
Xu Li
,
Ailsa Jarrold
,
Sally L Gras
An industrially applicable Escherichia coli platform for bioconversion of thebaine to oripavine and codeine to morphine.
Chemical communications (Cambridge, England)
59 (41) (2023)
Garrick W K Spencer
,
Xu Li
,
Ailsa Jarrold
,
Sally L Gras
An industrially applicable Escherichia coli platform for bioconversion of thebaine to oripavine and codeine to morphine.
Chemical communications (Cambridge, England)
59 (41) (2023)
Garrick W K Spencer
,
Xu Li
,
Ailsa Jarrold
,
Sally L Gras
An industrially applicable Escherichia coli platform for bioconversion of thebaine to oripavine and codeine to morphine.
Chemical communications (Cambridge, England)
(2023)
Garrick W K Spencer
,
Xu Li
,
Ailsa Jarrold
,
Sally L Gras
An industrially applicable Escherichia coli platform for bioconversion of thebaine to oripavine and codeine to morphine.
Chemical communications (Cambridge, England)
59 (41) (2023)